DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2018 Update

  • ID: 4315249
  • Company Profile
  • 107 pages
  • GlobalData
  • Diasorin
1 of 5

FEATURED COMPANIES

  • Biohit Oyj
  • Randox Laboratories Ltd
  • Roche Diagnostics SpA
  • Trinity Biotech Plc
  • MORE
DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DiaSorin S.p.A
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biohit Oyj
  • Randox Laboratories Ltd
  • Roche Diagnostics SpA
  • Trinity Biotech Plc
  • MORE
  • DiaSorin S.p.A Company Overview
  • DiaSorin S.p.A Company Snapshot
  • DiaSorin S.p.A Pipeline Products and Ongoing Clinical Trials Overview
  • DiaSorin S.p.A - Pipeline Analysis Overview
  • Business Description
  • DiaSorin S.p.A - Key Facts
  • DiaSorin S.p.A - Major Products and Services
  • DiaSorin S.p.A Pipeline Products by Development Stage
  • DiaSorin S.p.A Ongoing Clinical Trials by Trial Status
  • DiaSorin S.p.A Pipeline Products Overview
  • BCR-ABL ABL Assay
  • BCR-ABL ABL Assay Product Overview
  • BCR-ABL P190 + ABL Assay
  • BCR-ABL P190 + ABL Assay Product Overview
  • BCR-ABL v1.5 Assay
  • BCR-ABL v1.5 Assay Product Overview
  • C-Kit 816 Assay
  • C-Kit 816 Assay Product Overview
  • C-Kit 822 Assay
  • C-Kit 822 Assay Product Overview
  • Diagnostic Assay - Atypical Pneumonia
  • Diagnostic Assay - Atypical Pneumonia Product Overview
  • Diagnostic Assay - Chronic Kidney Disease
  • Diagnostic Assay - Chronic Kidney Disease Product Overview
  • Diagnostic Assay - Enteric Infection
  • Diagnostic Assay - Enteric Infection Product Overview
  • Diagnostic Assay - Fecal Occult Blood Assay
  • Diagnostic Assay - Fecal Occult Blood Assay Product Overview
  • Diagnostic Assay - GI Inflammation
  • Diagnostic Assay - GI Inflammation Product Overview
  • Diagnostic Assay - Group B Streptococcus Infection
  • Diagnostic Assay - Group B Streptococcus Infection Product Overview
  • Diagnostic Assay - HBsAg High Throughput
  • Diagnostic Assay - HBsAg High Throughput Product Overview
  • Diagnostic Assay - HCV II
  • Diagnostic Assay - HCV II Product Overview
  • Diagnostic Assay - HSV M + cntr
  • Diagnostic Assay - HSV M + cntr Product Overview
  • Diagnostic Assay - Lactoferrin Assay
  • Diagnostic Assay - Lactoferrin Assay Product Overview
  • Diagnostic Assay - Lipase Assay
  • Diagnostic Assay - Lipase Assay Product Overview
  • Diagnostic Assay - Mycoplasma Genitalium Infection
  • Diagnostic Assay - Mycoplasma Genitalium Infection Product Overview
  • Diagnostic Assay - Streptococcus Pneumonia
  • Diagnostic Assay - Streptococcus Pneumonia Product Overview
  • Diagnostic Assay - Vaginosis
  • Diagnostic Assay - Vaginosis Product Overview
  • Diagnostic Assay - Vector Borne Diseases
  • Diagnostic Assay - Vector Borne Diseases Product Overview
  • Estradiol II Assay
  • Estradiol II Assay Product Overview
  • H.Influenza B Assay
  • H.Influenza B Assay Product Overview
  • Human Herpes Virus 6 IgG EIA Assay
  • Human Herpes Virus 6 IgG EIA Assay Product Overview
  • Human Herpes Virus 8 IgG IFA Assay
  • Human Herpes Virus 8 IgG IFA Assay Product Overview
  • Hyperphosphate - High Bone Turnover Assay
  • Hyperphosphate - High Bone Turnover Assay Product Overview
  • LAMP CBF-MYH D Assay
  • LAMP CBF-MYH D Assay Product Overview
  • LAMP CBF-MYH E Assay
  • LAMP CBF-MYH E Assay Product Overview
  • LAMP VCA IgA Assay
  • LAMP VCA IgA Assay Product Overview
  • LIAISON - Anti-HDV Assay
  • LIAISON - Anti-HDV Assay Product Overview
  • LIAISON - Chlamydia P. IgA Assay
  • LIAISON - Chlamydia P. IgA Assay Product Overview
  • LIAISON - Chlamydia P. IgG Assay
  • LIAISON - Chlamydia P. IgG Assay Product Overview
  • LIAISON - High Sclerostin Assay
  • LIAISON - High Sclerostin Assay Product Overview
  • LIAISON - Hyperphosphate Low Bone Turnover Assay
  • LIAISON - Hyperphosphate Low Bone Turnover Assay Product Overview
  • LIAISON - Tg Gen II Assay
  • LIAISON - Tg Gen II Assay Product Overview
  • LIAISON IAM - Acute Lymphoblastic Leukemia Test
  • LIAISON IAM - Acute Lymphoblastic Leukemia Test Product Overview
  • LIAISON IAM - Acute Promyelocytic Leukemia Test
  • LIAISON IAM - Acute Promyelocytic Leukemia Test Product Overview
  • LIAISON IAM - EBV Assay
  • LIAISON IAM - EBV Assay Product Overview
  • LIAISON IAM - Myeloproliferative Neoplasm Assay
  • LIAISON IAM - Myeloproliferative Neoplasm Assay Product Overview
  • LIAISON XL - Chlamydia Pneumoniae Assay
  • LIAISON XL - Chlamydia Pneumoniae Assay Product Overview
  • LIAISON XL - H. Pylori Ag Assay
  • LIAISON XL - H. Pylori Ag Assay Product Overview
  • LIAISON XL - H. Pylori Ag Assay Clinical Trial
  • LIAISON XL - Hepatitis A Assay
  • LIAISON XL - Hepatitis A Assay Product Overview
  • LIAISON XL - Hepatitis B Assay
  • LIAISON XL - Hepatitis B Assay Product Overview
  • LIAISON XL - Hepatitis C Assay
  • LIAISON XL - Hepatitis C Assay Product Overview
  • Liaison XL - HIV
  • Liaison XL - HIV Product Overview
  • LIAISON XL - Parvovirus B19 Test
  • LIAISON XL - Parvovirus B19 Test Product Overview
  • LIAISON XL - Sclerostin Assay
  • LIAISON XL - Sclerostin Assay Product Overview
  • LIAISON XL Zika Capture IgM Assay
  • LIAISON XL Zika Capture IgM Assay Product Overview
  • LIAISON XL- Procalcitonin Assay
  • LIAISON XL- Procalcitonin Assay Product Overview
  • LIAISON XS
  • LIAISON XS Product Overview
  • Neisseria meningitidis Assay
  • Neisseria meningitidis Assay Product Overview
  • Parvovirus B19 IFA Assay
  • Parvovirus B19 IFA Assay Product Overview
  • PML-RAR Alpha BCR2 Assay
  • PML-RAR Alpha BCR2 Assay Product Overview
  • PML-RAR1 + ABL Assay
  • PML-RAR1 + ABL Assay Product Overview
  • PML-RAR2 + ABL Assay
  • PML-RAR2 + ABL Assay Product Overview
  • PML-RAR3 + ABL Assay
  • PML-RAR3 + ABL Assay Product Overview
  • Progesterone II Assay
  • Progesterone II Assay Product Overview
  • Quant ABL Assay
  • Quant ABL Assay Product Overview
  • Quant BCR-ABL p210 Assay
  • Quant BCR-ABL p210 Assay Product Overview
  • Reagent ASRs - Gastro-intestinal Infections
  • Reagent ASRs - Gastro-intestinal Infections Product Overview
  • Reagent ASRs - Genetic Disorders
  • Reagent ASRs - Genetic Disorders Product Overview
  • Reagent ASRs - Immuno-Compromised Disorders
  • Reagent ASRs - Immuno-Compromised Disorders Product Overview
  • Reagent ASRs - Infectious Disease
  • Reagent ASRs - Infectious Disease Product Overview
  • Reagent ASRs - Respiratory Disease
  • Reagent ASRs - Respiratory Disease Product Overview
  • Reagent ASRs - Vector-Borne Disease
  • Reagent ASRs - Vector-Borne Disease Product Overview
  • Respiratory Virus Panel
  • Respiratory Virus Panel Product Overview
  • Simplexa Bordetella Direct
  • Simplexa Bordetella Direct Product Overview
  • Simplexa Enterovirus Direct
  • Simplexa Enterovirus Direct Product Overview
  • Simplexa MRSA Direct
  • Simplexa MRSA Direct Product Overview
  • DiaSorin S.p.A - Key Competitors
  • DiaSorin S.p.A - Key Employees
  • DiaSorin S.p.A - Key Employee Biographies
  • DiaSorin S.p.A - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • DiaSorin S.p.A, Recent Developments
  • May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018
  • Apr 05, 2018: Diasorin Receives FDA Clearance For LIAISON BRAHMS PCT II GEN Assay To Detect Severe Bacterial Infections (Sepsis)
  • Mar 28, 2018: DiaSorin Earns FDA Clearance Extending Sample Claims For HSV 1 & 2 Test
  • Dec 12, 2017: Diasorin Launches A New Simplexa Bordetella Direct Molecular Test
  • Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed
  • Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus
  • Sep 21, 2017: Diasorin Earned CE-Mark Extending Sample Claims For Diasorin Molecular’s Simplexa HSV 1 & 2 Kit
  • Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017
  • Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus
  • Jul 10, 2017: Diasorin Launches IAM CBFB-MYH11, Completing The Diagnostic Test Menu For Molecular Screening Of Acute Myeloid Leukemia By Q-LAMP
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Trinity Biotech Plc
  • Roche Diagnostics SpA
  • Randox Laboratories Ltd
  • EKF Diagnostics Holdings Plc
  • Biohit Oyj
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll